Covid-19 vaccine updates: Over 250 register for Covaxin trial, Sputnik-V to reach Kanpur trial
A worldwide search for a vaccine to cure the coronavirus disease (Covid-19) continues as several countries across the world are busy battling resurgence of the outbreak. So far, as many as 53,945,763 people have been infected by the Covid-19 across the world, numbers published by the John Hopkins University show. Most of the fresh cases were reported from the United States and Europe. While 1,311,427 others have succumbed to the disease.
Here is what is happening in Covid-19 vaccine development front:
- The first batch of Russia’s Sputnik-V vaccine for Covid-19 is likely to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted. The Russian officials recently claimed that the Sputnik-V vaccine is 92% effective at protecting people from Covid-19 citing findings in the human trials.
- More than 250 applications have been received for the trial of Covid-19 vaccine ‘Covaxin’, one of the three vaccine candidates being developed in India, at the Jawaharlal Nehru Medical College Hospital of the Aligarh Muslim University.
- Johnson & Johnson will spend about $604 million expanding its deal with the US government to develop a Covid-19 vaccine. The Biomedical Advanced Research and Development Authority will commit about $454 million in additional money to the Phase 3 Ensemble trial, which seeks to evaluate the efficacy of the company’s vaccine candidate as a single-dose.
- Speaking at a last week, Union health minister of India Dr Harsh Vardhan said that the government has announced a USD 120 million grant for Covid-19 vaccine research. The grant will be provided under CovidSuraksha (Mission for protection from Covid) and is to be used purely for research and development in this field. India is also hosting clinical trials for all the major vaccine contenders. Serum Institute of India, the world’s largest vaccine manufacturer, is conducting trials for the vaccine developed by Oxford University, he had also informed.
(With agency inputs)
Enter your email to get our daily newsletter in your inbox
- Shah directed that additional central paramilitary forces be deployed in Delhi with immediate effect and individuals and groups behind the Red Fort seize be brought to justice.
- While more than 100,000 people attended the parade during the previous years, with Covid-19 norms in place on Tuesday, the crowd was limited to 25,000.
- The Opposition, including the Congress, alleges that the government rushed the farm laws without proper discussion in Parliament. The Centre, however, says the reforms will lead to new opportunities in agriculture trade.
- The parliament canteen, now run by ITDC will offer as many as 58 items, both vegetarian and non-vegetarian, from January 27.
- Union minister for culture and tourism Prahlad Patel said government is addressing the lack of adventure sports equipment in Kargil.
- In contrast to the violence seen in the Capital, farmers held peaceful rallies across the country to protest against the farm laws.
- India put on display its war machines at a time when the country is locked in a tense border stand-off with China.
- The chaos and violence have raised questions about the future of the two-month-long agitation of farm unions.
- Bangladesh Prime Minister Sheikh Hasina, in a letter sent to her Indian counterpart, conveyed her greetings.
- Tuesday's decision to operate all trains comes a day after a meeting to resume local train services for all passengers was chaired by Maharashtra chief minister Uddhav Thackeray.
- Khattar said that unsavoury events on Tuesday deserved to be condemned in the strongest words.
- Governor RN Ravi said 'politics by gun' has stonewalled efforts to resolve the Naga political issue.